05:00 PM EDT, 04/15/2024 (MT Newswires) -- Brian Mulroy, Chief Financial Officer, on April 11, 2024, sold 89,079 shares in Semrush Holdings ( SEMR ) for $1,148,228. Following the Form 4 filing with the SEC, Mulroy has control over a total of 441,625 shares of the company, with 441,625 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1831840/000183184024000017/xslF345X03/wk-form4_1713214696.xml ...

05:01 PM EDT, 04/15/2024 (MT Newswires) -- James Dimon, Director, Chairman & CEO, on April 15, 2024, sold 178,222 shares in Jpmorgan Chase ( JPM ) & (JPM) for $32,824,625. Following the Form 4 filing with the SEC, Dimon has control over a total of 7,662,091 shares of the company, with 264,461 shares held directly and 7,397,630 controlled indirectly. SEC...

05:05 PM EDT, 04/15/2024 (MT Newswires) -- MFA Financial ( MFA/PB ) said late Monday it priced an underwritten public offering of $75 million of 9.0% senior notes due 2029. Underwriters, including Morgan Stanley and RBC Capital Markets, have the option to purchase up to an additional $11.25 million of notes, the company added. It expects to close the offering...

05:00 PM EDT, 04/15/2024 (MT Newswires) -- ORIC Pharmaceuticals ( ORIC ) said late Monday it dosed the first patients in three dose expansion groups in a phase 1b trial of ORIC-114 in people with lung cancer. The phase 1b expansion part of the study will assess the safety and efficacy of the candidate drug at the provisional recommended phase...